<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">BMC Complement Altern Med</journal-id><journal-id journal-id-type="iso-abbrev">BMC Complement Altern Med</journal-id><journal-title-group><journal-title>BMC Complementary and Alternative Medicine</journal-title></journal-title-group><issn pub-type="epub">1472-6882</issn><publisher><publisher-name>BioMed Central</publisher-name><publisher-loc>London</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">28482839</article-id><article-id pub-id-type="pmc">5422894</article-id><article-id pub-id-type="publisher-id">1741</article-id><article-id pub-id-type="doi">10.1186/s12906-017-1741-0</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title>The effects of <italic>Alkanna tinctoria</italic> Tausch on split-thickness skin graft donor site management: a randomized, blinded placebo-controlled trial</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Kheiri</surname><given-names>Aliasghar</given-names></name><address><email>Dkheiri@yahoo.com</email></address><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Amini</surname><given-names>Shahideh</given-names></name><address><email>Aminishahideh@yahoo.com</email></address><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author"><name><surname>Javidan</surname><given-names>Abbas Norouzi</given-names></name><address><email>noroozia@tums.ac.ir</email></address><xref ref-type="aff" rid="Aff3">3</xref></contrib><contrib contrib-type="author"><name><surname>Saghafi</surname><given-names>Mohammad Mehdi</given-names></name><address><email>mmehdi.paf@gmail.com</email></address><xref ref-type="aff" rid="Aff4">4</xref></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-8608-4919</contrib-id><name><surname>Khorasani</surname><given-names>Ghasemali</given-names></name><address><email>Gakhorasani@yahoo.com</email></address><xref ref-type="aff" rid="Aff1">1</xref></contrib><aff id="Aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0001 0166 0922</institution-id><institution-id institution-id-type="GRID">grid.411705.6</institution-id><institution>Plastic and Reconstructive Surgery Division, Faculty of Medicine, </institution><institution>Tehran University of Medical Sciences, </institution></institution-wrap>Tehran, Iran </aff><aff id="Aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0001 0166 0922</institution-id><institution-id institution-id-type="GRID">grid.411705.6</institution-id><institution>Clinical Pharmacy Department, Faculty of Pharmacy, </institution><institution>Tehran University of Medical Sciences, </institution></institution-wrap>Tehran, Iran </aff><aff id="Aff3"><label>3</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0001 0166 0922</institution-id><institution-id institution-id-type="GRID">grid.411705.6</institution-id><institution>Brain and Spinal Injury Research Center, Institute of Neuroscience, </institution><institution>Tehran University of Medical Sciences, </institution></institution-wrap>Tehran, Iran </aff><aff id="Aff4"><label>4</label><institution-wrap><institution-id institution-id-type="GRID">grid.411746.1</institution-id><institution>Pharmacology Department, Faculty of Pharmacy, </institution><institution>Iran University of Medical Sciences, </institution></institution-wrap>Tehran, Iran </aff></contrib-group><pub-date pub-type="epub"><day>8</day><month>5</month><year>2017</year></pub-date><pub-date pub-type="pmc-release"><day>8</day><month>5</month><year>2017</year></pub-date><pub-date pub-type="collection"><year>2017</year></pub-date><volume>17</volume><elocation-id>253</elocation-id><history><date date-type="received"><day>11</day><month>4</month><year>2016</year></date><date date-type="accepted"><day>13</day><month>4</month><year>2017</year></date></history><permissions><copyright-statement>&#x000a9; The Author(s). 2017</copyright-statement><license license-type="OpenAccess"><license-p>
<bold>Open Access</bold>This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/publicdomain/zero/1.0/">http://creativecommons.org/publicdomain/zero/1.0/</ext-link>) applies to the data made available in this article, unless otherwise stated.</license-p></license></permissions><abstract id="Abs1"><sec><title>Background</title><p>A prospective, randomized, placebo-controlled clinical trial was conducted to compare the healing effectiveness of <italic>Alkanna tinctoria</italic> (L.) Tausch (Boraginaceae) with standard dressing on wound healing at the donor site after removal of the skin graft.</p></sec><sec><title>Methods</title><p>Enrolled patients were randomly allocated to receive topical<italic>A. tinctoria</italic> extract ointment (20%) or standard dressing (dressing with base ointment) daily. Wound healing was assessed using the Bates-Jenson assessment tool at the 2<sup>nd</sup> and 4<sup>th</sup> weeks after intervention.</p></sec><sec><title>Results</title><p>Decreases in wound score were significantly greater in the <italic>A. tinctoria</italic> group compared with the placebo group (<italic>P &#x0003c;</italic>0.05). The surface areas of graft donor sites in the <italic>A. tinctoria</italic> group were significantly reduced as compared with the control group at day 28 of the intervention (<italic>P&#x02009;&#x0003c;</italic>&#x02009;0.05). The proportion of patients in the <italic>A. tinctoria</italic> group achieving complete wound healing within 2 to 4&#x000a0;weeks was 50% and 96.66%, respectively, significantly higher than in patients receiving standard care: 0% and 23.3%, respectively.</p></sec><sec><title>Conclusions</title><p>This clinical study showed that <italic>A. tinctoria</italic> dressing accelerates wound healing after graft harvesting.</p></sec><sec><title>Trial registration</title><p>IRCT ID: <ext-link ext-link-type="uri" xlink:href="http://www.irct.ir/searchresult.php?id=5781&#x00026;number=2">IRCT201511165781N2</ext-link>.</p></sec></abstract><kwd-group xml:lang="en"><title>Keywords</title><kwd><italic>Alkanna</italic></kwd><kwd>Skin graft</kwd><kwd>Wound</kwd><kwd>Healing</kwd></kwd-group><custom-meta-group><custom-meta><meta-name>issue-copyright-statement</meta-name><meta-value>&#x000a9; The Author(s) 2017</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="Sec1" sec-type="introduction"><title>Background</title><p>Split-thicknesses skin graft (STSG) is a beneficial technique used to enhance wound healing. However, donor site management after skin graft harvesting is an important issue in reconstructive surgery [<xref ref-type="bibr" rid="CR1">1</xref>]. The ideal dressing accelerates the healing process, prevents infectious complications and is easy to apply and cost effective [<xref ref-type="bibr" rid="CR2">2</xref>, <xref ref-type="bibr" rid="CR3">3</xref>]. Several dressings and topical agents have been applied clinically for wound healing at the donor site, but the optimum dressing agents or uniform standard dressing for local wound care is unclear. However, no evidence has documented any superiority or advantage of a particular dressing [<xref ref-type="bibr" rid="CR2">2</xref>, <xref ref-type="bibr" rid="CR4">4</xref>, <xref ref-type="bibr" rid="CR5">5</xref>]. The process of wound healing after skin graft harvesting depends markedly on the extent of inflammation and infection [<xref ref-type="bibr" rid="CR6">6</xref>, <xref ref-type="bibr" rid="CR7">7</xref>]. <italic>Alkanna tinctoria</italic> (L.) Tausch (Boraginaceae) (<italic>A. tinctoria</italic>) is a historical plant that has been used for the treatment of macular eruptions and infectious diseases, such as measles, sore-throat, carbuncles and burns, and has also been used as a dye in the cosmetic and fabric industries. Since ancient times, roots extracted from <italic>A. Tinctoria</italic> have been used to treat wounds [<xref ref-type="bibr" rid="CR8">8</xref>, <xref ref-type="bibr" rid="CR9">9</xref>]. The main active ingredients of <italic>A. Tinctoria</italic> are Alkannin and shikonin (A/S) [<xref ref-type="bibr" rid="CR8">8</xref>]. Alkannin derivatives show strong wound healing along with anti-inflammatory and antimicrobial properties [<xref ref-type="bibr" rid="CR10">10</xref>, <xref ref-type="bibr" rid="CR11">11</xref>]. Although the wound-healing effect of <italic>A. tinctorial</italic> was first identified in 1976, in the era of modern medicine, the use of this plant has declined [<xref ref-type="bibr" rid="CR10">10</xref>, <xref ref-type="bibr" rid="CR12">12</xref>]. The purpose of this study was to evaluate the healing effectiveness of (<italic>A. tinctoria</italic>) Tausch dressing for STSG donor site coverage compared with standard dressing at the donor site after removal of the skin graft.</p></sec><sec id="Sec2" sec-type="materials|methods"><title>Methods</title><p>A prospective, randomized, placebo-controlled clinical trial was conducted between October 2015 and January 2016 at Vali-Asr Hospital, a tertiary university hospital in Tehran. The study protocol was approved by the Ethics committee of Tehran University of Medical Science and written informed consent was obtained from all participants after registration of the study in the Iranian Registry of Clinical Trials (IRCT) (IRCT201511165781N2). Patients undergoing skin graft harvest from the thigh for treatment of trauma, scars or tumours were included in this study. Patients with a history of hypersensitivity reaction to the topical formulation, those who were unwilling to participate in the study and those suffering from diseases that could interfere with wound healing, such as diabetes, renal failure, liver failure, malnourishment, cancer and hypoalbuminemia (serum albumin &#x0003c;4&#x000a0;g/dl), as well as elderly (age&#x02009;&#x0003e;&#x02009;60&#x000a0;years) and pregnant patients, were excluded from the study (Fig.&#x000a0;<xref rid="Fig1" ref-type="fig">1</xref>).<fig id="Fig1"><label>Fig. 1</label><caption><p>Consort flowchart of the study.*Seven diabetic patients, three patients with chronic kidney disease and five patients who were unwilling to participate in the study were excluded</p></caption><graphic xlink:href="12906_2017_1741_Fig1_HTML" id="MO1"/></fig>
</p><p>After the patients were administered general anaesthesia, the donor site was prepared with 10% povidone iodine solution. All skin grafts were harvested to a thickness of 0.4&#x000a0;mm from the antero-lateral thigh region with an electric Dermatome (Humeca).</p><p>Participants who met the eligibility criteria were randomized in to one of two groups by using a block randomization: <italic>A. Tinctoria</italic> cream (group A [<italic>n</italic>&#x02009;=&#x02009;30]) and placebo cream (base cream without <italic>A. tinctoria</italic> extract, group B [<italic>n</italic>&#x02009;=&#x02009;30]). The randomization sequence was generated by a statistician and maintained by an administrator who had no other involvement in the trial. One of the main researchers recruited patients on the basis of a randomization sequence. In the operating room, wounds were dressed and bandaged. The study group received topical <italic>A. tinctoria</italic> ointment daily, whereas the control group received daily topical application of placebo ointment (petrolatum gauze along with several sterile gauzes). The <italic>A. tinctoria</italic> ointment and placebo ointment were identical in weight, appearance, texture and colour. They were only recognizable by a code (A or B). The researchers and the subjects were blinded to the content of the ointment throughout the study and during the statistical analysis. After 2&#x000a0;days, according to the protocol, the donor site dressing was changed daily. At each visit, the percentage of healing at the donor site, as well as signs of infection, were recorded. The primary outcome measure was wound healing, which was assessed visually and photographically by the change in wound score according to the Bates-Jensen wound assessment tool at days 14 and 28 after the intervention. The outcome assessor was blinded to the participants&#x02019; allocation.</p><p>According to the sample size formula, we defined alpha (&#x003b1;) as the significance level (set at 0.05 consistent with 1&#x02013;&#x003b1; or 95% in the context of confidence intervals) and beta (&#x003b2;) as the probability of making a type II error and standard deviation of the outcome variables. According to this formula and assumption of a 10% dropout rate, 30 patients in each group were considered. On the basis of the Bates-Jensen wound assessment between two groups in one week as a pilot study, &#x003bc;<sub>1</sub>and &#x003bc;<sub>2</sub>were also defined.<disp-formula id="Equa"><alternatives><tex-math id="M1">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$ \begin{array}{l}\alpha =0.05,\ \beta =0.001,{Z}^1- a/2=1.961150776,\ {Z}^1- B=3.090273048\\ {}{\mu}_1=8.6,\ {\mu}_2=28.6,\ {\sigma}_1=7.3,\ {\sigma}_2=7.4\\ {} n=\frac{{\left( z1-\frac{a}{2}+ z1-\beta \right)}^2\left(\sigma {1}^2+{\sigma}^22\right)}{{\left(\mu 1-\mu 2\right)}^2}\end{array} $$\end{document}</tex-math><mml:math id="M2"><mml:mtable columnalign="left"><mml:mtr><mml:mtd><mml:mi>&#x003b1;</mml:mi><mml:mo>=</mml:mo><mml:mn>0.05</mml:mn><mml:mo>,</mml:mo><mml:mspace width="0.25em"/><mml:mi>&#x003b2;</mml:mi><mml:mo>=</mml:mo><mml:mn>0.001</mml:mn><mml:mo>,</mml:mo><mml:msup><mml:mi>Z</mml:mi><mml:mn>1</mml:mn></mml:msup><mml:mo>&#x02212;</mml:mo><mml:mi>a</mml:mi><mml:mo stretchy="true">/</mml:mo><mml:mn>2</mml:mn><mml:mo>=</mml:mo><mml:mn>1.961150776</mml:mn><mml:mo>,</mml:mo><mml:mspace width="0.25em"/><mml:msup><mml:mi>Z</mml:mi><mml:mn>1</mml:mn></mml:msup><mml:mo>&#x02212;</mml:mo><mml:mi>B</mml:mi><mml:mo>=</mml:mo><mml:mn>3.090273048</mml:mn></mml:mtd></mml:mtr><mml:mtr><mml:mtd><mml:msub><mml:mi>&#x003bc;</mml:mi><mml:mn>1</mml:mn></mml:msub><mml:mo>=</mml:mo><mml:mn>8.6</mml:mn><mml:mo>,</mml:mo><mml:mspace width="0.25em"/><mml:msub><mml:mi>&#x003bc;</mml:mi><mml:mn>2</mml:mn></mml:msub><mml:mo>=</mml:mo><mml:mn>28.6</mml:mn><mml:mo>,</mml:mo><mml:mspace width="0.25em"/><mml:msub><mml:mi>&#x003c3;</mml:mi><mml:mn>1</mml:mn></mml:msub><mml:mo>=</mml:mo><mml:mn>7.3</mml:mn><mml:mo>,</mml:mo><mml:mspace width="0.25em"/><mml:msub><mml:mi>&#x003c3;</mml:mi><mml:mn>2</mml:mn></mml:msub><mml:mo>=</mml:mo><mml:mn>7.4</mml:mn></mml:mtd></mml:mtr><mml:mtr><mml:mtd><mml:mi>n</mml:mi><mml:mo>=</mml:mo><mml:mfrac><mml:mrow><mml:msup><mml:mfenced close=")" open="("><mml:mrow><mml:mi>z</mml:mi><mml:mn>1</mml:mn><mml:mo>&#x02212;</mml:mo><mml:mfrac><mml:mi>a</mml:mi><mml:mn>2</mml:mn></mml:mfrac><mml:mo>+</mml:mo><mml:mi>z</mml:mi><mml:mn>1</mml:mn><mml:mo>&#x02212;</mml:mo><mml:mi>&#x003b2;</mml:mi></mml:mrow></mml:mfenced><mml:mn>2</mml:mn></mml:msup><mml:mfenced close=")" open="("><mml:mrow><mml:mi>&#x003c3;</mml:mi><mml:msup><mml:mn>1</mml:mn><mml:mn>2</mml:mn></mml:msup><mml:mo>+</mml:mo><mml:msup><mml:mi>&#x003c3;</mml:mi><mml:mn>2</mml:mn></mml:msup><mml:mn>2</mml:mn></mml:mrow></mml:mfenced></mml:mrow><mml:msup><mml:mfenced close=")" open="("><mml:mrow><mml:mi>&#x003bc;</mml:mi><mml:mn>1</mml:mn><mml:mo>&#x02212;</mml:mo><mml:mi>&#x003bc;</mml:mi><mml:mn>2</mml:mn></mml:mrow></mml:mfenced><mml:mn>2</mml:mn></mml:msup></mml:mfrac></mml:mtd></mml:mtr></mml:mtable></mml:math><graphic xlink:href="12906_2017_1741_Article_Equa.gif" position="anchor"/></alternatives></disp-formula>
</p><sec id="Sec3"><title>Preparation of Topical Formulation</title><p>Root of <italic>A. tinctoria</italic>, Vaseline, beeswax and sesame oil was used to formulate an <italic>A. Tinctoria</italic> (20%) ointment base. The final product was sterilized by gamma irradiation (25&#x000a0;kGy) to eliminate bacterial spores. The <italic>A. tinctoria</italic>-based ointment was provided by Daru Darman pharmaceutical lab (approved by the Iranian Health Authorities). A placebo ointment, consisting of the base formulation only without <italic>A. tinctoria</italic>, was also prepared.</p></sec><sec id="Sec4"><title>Toxicity Assessment</title><p>In a preliminary study, skin irritation due to this product was evaluated by the Driaiz Primary Skin Test [<xref ref-type="bibr" rid="CR13">13</xref>, <xref ref-type="bibr" rid="CR14">14</xref>]. In this method, topical product was applied to the skin of animals (rabbits), and any signs of erythema and oedema were evaluated. No irritation (primary irritation index (PII)&#x02009;=&#x02009;0) was observed in animals (data not shown).</p></sec><sec id="Sec5"><title>Wound Evaluation</title><p>Wound healing was assessed by the change in wound score according to the Bates-Jensen wound assessment tool. The Bates-Jensen wound assessment tool contains 13 items that assess wound size, depth, edges, undermining, necrotic tissue type, amount of necrosis, granulation and epithelialization tissue, exudate type and amount, surrounding skin colour, oedema and induration. These are rated on a modified Likert scale; the highest score indicates the unhealthiest wound. Each item was rated on a modified Likert scale and finally, the total score was obtained by adding together the 13-item scores. The Bates-Jensen wound assessment tool is available to use free with permission from the author at:</p><p>
<ext-link ext-link-type="uri" xlink:href="http://www.geronet.med.ucla.edu/centers/borun/modules/Pressure_ulcer_prevention/puBWAT.pdf">http://www.geronet.med.ucla.edu/centers/borun/modules/Pressure_ulcer_prevention/puBWAT.pdf</ext-link>)</p><p>In addition, signs of infection were assessed during the study.</p></sec><sec id="Sec6"><title>Data analysis</title><p>The data were analysed using SPSS version 18.0 software. Both the Student&#x02019;s <italic>t</italic>- test and analysis of variance (ANOVA) were used to compare the wound score and wound surface area between the two groups and all two groups, respectively. The changes in the stage of healing during study were analysed by using repeated-measures ANOVA. Results were considered significant at <italic>P</italic>&#x02009;&#x0003c;&#x02009;0.05. A chi-square test was used for descriptive variables.</p></sec></sec><sec id="Sec7" sec-type="results"><title>Results</title><p>Among the included patients, 30 patients (21 males and 9 females) in the <italic>A. tinctoria</italic> group and 30 patients (23 males and 7 females) in the control group completed the study (Fig.&#x000a0;<xref rid="Fig1" ref-type="fig">1</xref>). There was no significant difference in the demographic data between the two groups (Table&#x000a0;<xref rid="Tab1" ref-type="table">1</xref>).<table-wrap id="Tab1"><label>Table 1</label><caption><p>Characteristics of the patients</p></caption><table frame="hsides" rules="groups"><thead><tr><th>Variable</th><th>Control group</th><th>
<italic>Alkanna tinctoria</italic> group</th><th>
<italic>P</italic>-value</th></tr></thead><tbody><tr><td>Age, mean (SD), years</td><td>36.40&#x02009;&#x000b1;&#x02009;11.48</td><td>37.13&#x02009;&#x000b1;&#x02009;12.06</td><td>0.8</td></tr><tr><td colspan="4">Sex</td></tr><tr><td>&#x02003;Male, <italic>n</italic> (%)</td><td>22(73.3%)</td><td>21(70%)</td><td>0.7</td></tr><tr><td>&#x02003;Female, <italic>n</italic> (%)</td><td>8(26.6%)</td><td>9 (30%)</td><td/></tr></tbody></table></table-wrap>
</p><p>To evaluate wound healing, the grade and surface area of the skin graft donor site were compared at days 14 and 28 after the intervention (Table&#x000a0;<xref rid="Tab2" ref-type="table">2</xref>). There was no significant difference in wound scores of both groups at baseline, but the decrease in wound scores was significantly higher in the <italic>A. tinctoria</italic> group as compared with the placebo group at days 14 and 28 after the dressing was applied. In addition, the wound surface area was significantly reduced in the <italic>A. tinctoria</italic> group as compared with the control group following 28&#x000a0;days of intervention. The mean widths of the scar were 7.37&#x02009;&#x000b1;&#x02009;9.45&#x000a0;mm and 0.00&#x02009;&#x000b1;&#x02009;0.00&#x000a0;mm in the case group, whereas these values were 53&#x02009;&#x000b1;&#x02009;37.82&#x000a0;mm and 1.37&#x02009;&#x000b1;&#x02009;3.43&#x000a0;mm in control group at 14 and 28&#x000a0;days, respectively (<italic>P</italic>&#x02009;&#x0003c;&#x02009;0.05). No adverse effects were seen in either group treated with herbal and placebo ointments.<table-wrap id="Tab2"><label>Table 2</label><caption><p>Score comparison and surface area between the groups</p></caption><table frame="hsides" rules="groups"><thead><tr><th>Variable</th><th>Day<sup>a</sup>
</th><th>Control group</th><th>
<italic>Alkanna tinctoria</italic> group</th><th>
<italic>P</italic>-value</th></tr></thead><tbody><tr><td rowspan="3">Wound score<sup>b</sup> mean&#x02009;&#x000b1;&#x02009;(SD)</td><td>0</td><td>25.17&#x02009;&#x000b1;&#x02009;7.42</td><td>25.07&#x02009;&#x000b1;&#x02009;7.24</td><td>0.08</td></tr><tr><td>14</td><td>20.63&#x02009;&#x000b1;&#x02009;6.64</td><td>9.97&#x02009;&#x000b1;&#x02009;1.30</td><td>0.001</td></tr><tr><td>28</td><td>11.83&#x02009;&#x000b1;&#x02009;2.77</td><td>9.03&#x02009;&#x000b1;&#x02009;0.18</td><td>0.001</td></tr><tr><td rowspan="2">Patients with Wound score &#x0003c;10, <italic>n</italic> (%)</td><td>14</td><td>0</td><td>15 (50%)</td><td>0.001</td></tr><tr><td>28</td><td>7(23.3%)</td><td>29(96.66%)</td><td>0.001</td></tr></tbody></table><table-wrap-foot><p>
<sup>a</sup>Days after the intervention</p><p>
<sup>b</sup>Score according to the Bates-Jensen wound assessment tool</p></table-wrap-foot></table-wrap>
</p></sec><sec id="Sec8" sec-type="discussion"><title>Discussion</title><p>The primary study outcome was the percentage change in wound score according to the Bates-Jensen wound assessment tool after 4&#x000a0;weeks of treatment with <italic>A. tinctoria</italic> extract ointment (20%) or standard daily dressing (dressing with base ointment) at the split-thickness skin graft donor site. Secondary outcomes included the percentage change in wound surface area, the proportion of patients who achieved complete healing and the adverse effects of dressing with <italic>A. tinctoria</italic> extract ointment. To the best of our knowledge, this is the first clinical study to evaluate the healing effect of <italic>A. tinctoria</italic> on the split-thickness skin graft donor site. Our results suggest that a dressing providing a moist environment gives beneficial effects [<xref ref-type="bibr" rid="CR2">2</xref>, <xref ref-type="bibr" rid="CR15">15</xref>, <xref ref-type="bibr" rid="CR16">16</xref>]. Under optimal conditions, the skin graft donor site heals within 7 to 21&#x000a0;days [<xref ref-type="bibr" rid="CR16">16</xref>]. A proper wound dressing may reduce the time to complete re-epithelialization and to prevent conversion of the donor site to a full-thickness wound [<xref ref-type="bibr" rid="CR15">15</xref>, <xref ref-type="bibr" rid="CR17">17</xref>, <xref ref-type="bibr" rid="CR18">18</xref>]. The healing process occurs in three phases of inflammation, proliferation, and maturation [<xref ref-type="bibr" rid="CR19">19</xref>, <xref ref-type="bibr" rid="CR20">20</xref>]. It is established that the inflammatory phase has the greatest impact on the healing process [<xref ref-type="bibr" rid="CR21">21</xref>]. Alkannin, shikonin and their esters are the main ingredients in <italic>A. tinctoria</italic> that have anti-inflammatory, antimicrobial and antioxidant properties and promote wound healing [<xref ref-type="bibr" rid="CR10">10</xref>, <xref ref-type="bibr" rid="CR12">12</xref>, <xref ref-type="bibr" rid="CR22">22</xref>]. Previous studies showed that alkannin/shikonin (A/S) had wound-healing effects on chronic ulcers, leprotic ulcers, burn injuries and anal fissures [<xref ref-type="bibr" rid="CR10">10</xref>, <xref ref-type="bibr" rid="CR12">12</xref>]. As mentioned earlier, no studies have reported the wound-healing activity of A/Son split-thickness skin graft donor sites. The anti-inflammatory activity of A/S accelerates wound healing. In our study, decreases in wound score were significantly higher in the<italic>A. tinctoria</italic>group. More specifically, we found that the proportion of patients who achieved complete healing increased with use of the alkannin/shikonin (A/S)-based ointment. Other clinical studies showed that A/Shad healing effects in cases of chronic, severe or contaminated wounds. Furthermore, animal studies showed promotion of angiogenesis, collagen production and epithelialization in acute, non-contaminated wounds by the A/S-based ointment [<xref ref-type="bibr" rid="CR23">23</xref>, <xref ref-type="bibr" rid="CR24">24</xref>]. Previously, it was indicated that the <italic>Aloe vera</italic> cream enhanced wound healing compared with dry gauze dressing; this may have been due to the moisture-retaining effect of <italic>Aloe vera</italic> on the wounds, but in the present study, it appears as though the pharmacologic properties of A/S were responsible for the observed effects [<xref ref-type="bibr" rid="CR25">25</xref>]. These results indicate that wound-healing pharmaceutical preparations, such as A/S-based ointment, which modulates both inflammatory and proliferative phases of wound healing, maybe more efficient than standard dressing for donor site management after skin graft harvesting.</p></sec><sec id="Sec9" sec-type="conclusion"><title>Conclusion</title><p>A topical cream containing <italic>A. tinctoria</italic> exhibited the highest rates of complete healing, and wounds to which it was applied healed significantly faster than those bandaged with standard dressing.</p><sec id="Sec10"><title>Limitations</title><p>In this study, pain scores during dressing changes were not evaluated. In addition, this short-term study did not enable us to evaluate scar appearance.</p></sec></sec></body><back><glossary><title>Abbreviations</title><def-list><def-item><term><italic>A. tinctoria</italic></term><def><p>
<italic>Alkannatinctoria</italic>
</p></def></def-item><def-item><term>A/S</term><def><p>Alkannin and shikonin</p></def></def-item><def-item><term>STSG</term><def><p>Split-thicknesses skin grafts</p></def></def-item></def-list></glossary><ack><title>Acknowledgements</title><p>We thank all the participants who contributed and made the study possible. This work was supported by the Brain and Spinal Injury Research Centre, Institute of Neuroscience, Tehran University of Medical Sciences.</p><sec id="FPar1"><title>Funding</title><p>This study was supported by the Brain and Spinal Injury Research Centre, Institute of Neuroscience, Tehran University of Medical Sciences. This centre had no influence over how this study was designed or performed.</p></sec><sec id="FPar2"><title>Availability of data and materials</title><p>Not relevant to this research.</p></sec><sec id="FPar3"><title>Authors&#x02019; contributions</title><p>GK and AN together carried out the design of the study, the clinical trial registration and the ethical approval process. AK handled the recruitment of the participants and the research data. SA and MS handled the research data and conducted the statistical analysis of the data, wrote the manuscript and made revisions. All authors read and approved the final manuscript.</p></sec><sec id="FPar4"><title>Competing interests</title><p>The authors declare that they have no competing interests.</p></sec><sec id="FPar5"><title>Consent for publication</title><p>Consent to publish is not relevant to this research.</p></sec><sec id="FPar6"><title>Ethics approval and consent to participate</title><p>The protocol for this study was approved by the Ethical Board of Tehran University of Medical Science (9211256005). The study is registered in The Iran Clinical Trial Registry. (IRCT ID: IRCT201511165781N2). Date of registration: 23 November 2015.</p><p>Written informed consent was obtained from all participants prior to study participation. All participants received sufficient information on the study content, and they were informed that they would receive all therapeutic treatments if they decided not to continue in the study.</p></sec><sec id="FPar7"><title>Publisher&#x02019;s Note</title><p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></sec></ack><ref-list id="Bib1"><title>References</title><ref id="CR1"><label>1.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Geary</surname><given-names>PM</given-names></name><name><surname>Tiernan</surname><given-names>E</given-names></name></person-group><article-title>Management of split skin graft donor sites-results of a national survey</article-title><source>Clin Plast Surg</source><year>2012</year><volume>39</volume><issue>1</issue><fpage>77</fpage><lpage>84</lpage><pub-id pub-id-type="doi">10.1016/j.cps.2011.09.012</pub-id><pub-id pub-id-type="pmid">22099851</pub-id></element-citation></ref><ref id="CR2"><label>2.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Voineskos</surname><given-names>SH</given-names></name><name><surname>Ayeni</surname><given-names>OA</given-names></name><name><surname>McKnight</surname><given-names>L</given-names></name><name><surname>Thoma</surname><given-names>A</given-names></name></person-group><article-title>Systematic review of skin graft donor-site dressings</article-title><source>Plast Reconstr Surg</source><year>2009</year><volume>124</volume><issue>1</issue><fpage>298</fpage><lpage>306</lpage><pub-id pub-id-type="doi">10.1097/PRS.0b013e3181a8072f</pub-id><pub-id pub-id-type="pmid">19568092</pub-id></element-citation></ref><ref id="CR3"><label>3.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Terrill</surname><given-names>PJ</given-names></name><name><surname>Goh</surname><given-names>RC</given-names></name><name><surname>Bailey</surname><given-names>MJ</given-names></name></person-group><article-title>Split-thickness skin graft donor sites: a comparative study of two absorbent dressings</article-title><source>J Wound Care</source><year>2007</year><volume>16</volume><issue>10</issue><fpage>433</fpage><lpage>8</lpage><pub-id pub-id-type="doi">10.12968/jowc.2007.16.10.27912</pub-id><pub-id pub-id-type="pmid">18065019</pub-id></element-citation></ref><ref id="CR4"><label>4.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Walter</surname><given-names>CJ</given-names></name><name><surname>Dumville</surname><given-names>JC</given-names></name><name><surname>Sharp</surname><given-names>CA</given-names></name><name><surname>Page</surname><given-names>T</given-names></name></person-group><article-title>Systematic review and meta-analysis of wound dressings in the prevention of surgical-site infections in surgical wounds healing by primary intention</article-title><source>Br J Surg</source><year>2012</year><volume>99</volume><issue>9</issue><fpage>1185</fpage><lpage>94</lpage><pub-id pub-id-type="doi">10.1002/bjs.8812</pub-id><pub-id pub-id-type="pmid">22777875</pub-id></element-citation></ref><ref id="CR5"><label>5.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Eskes</surname><given-names>AM</given-names></name><name><surname>Br&#x000f6;lmann</surname><given-names>FE</given-names></name><name><surname>Gerbens</surname><given-names>LA</given-names></name><name><surname>Ubbink</surname><given-names>DT</given-names></name><name><surname>Vermeulen</surname><given-names>H</given-names></name></person-group><article-title>REMBRANDT study group. Which dressing do donor site wounds need? Study protocol for a randomized controlled trial</article-title><source>Trials</source><year>2011</year><pub-id pub-id-type="pmid">21999705</pub-id></element-citation></ref><ref id="CR6"><label>6.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Loeffelbein</surname><given-names>DJ</given-names></name><name><surname>Rohleder</surname><given-names>NH</given-names></name><name><surname>Eddicks</surname><given-names>M</given-names></name><name><surname>Baumann</surname><given-names>CM</given-names></name><name><surname>Stoeckelhuber</surname><given-names>M</given-names></name><name><surname>Wolff</surname><given-names>KD</given-names></name><etal/></person-group><article-title>Evaluation of human amniotic membrane as a wound dressing for split-thickness skin-graft donor sites</article-title><source>Biomed Res Int</source><year>2014</year><pub-id pub-id-type="pmid">25003117</pub-id></element-citation></ref><ref id="CR7"><label>7.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Junker</surname><given-names>JP</given-names></name><name><surname>Kamel</surname><given-names>RA</given-names></name><name><surname>Caterson</surname><given-names>EJ</given-names></name><name><surname>Eriksson</surname><given-names>E</given-names></name></person-group><article-title>Clinical impact upon wound healing and inflammation in moist, wet, and dry environments</article-title><source>Adv Wound Care</source><year>2013</year><volume>2</volume><issue>7</issue><fpage>348</fpage><lpage>56</lpage><pub-id pub-id-type="doi">10.1089/wound.2012.0412</pub-id></element-citation></ref><ref id="CR8"><label>8.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>X</given-names></name><name><surname>Yang</surname><given-names>L</given-names></name><name><surname>Oppenheim</surname><given-names>JJ</given-names></name><name><surname>Howard</surname><given-names>MZ</given-names></name></person-group><article-title>Cellular pharmacology studies of shikonin derivatives</article-title><source>Phytother Res</source><year>2002</year><volume>16</volume><issue>3</issue><fpage>199</fpage><lpage>209</lpage><pub-id pub-id-type="doi">10.1002/ptr.1100</pub-id><pub-id pub-id-type="pmid">12164262</pub-id></element-citation></ref><ref id="CR9"><label>9.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Apageorgiou</surname><given-names>VP</given-names></name><name><surname>Assimopoulou</surname><given-names>AN</given-names></name><name><surname>Couladouros</surname><given-names>EA</given-names></name><name><surname>Hepworth</surname><given-names>D</given-names></name><name><surname>Nicolaouet</surname><given-names>KC</given-names></name></person-group><article-title>Chemistry and biology of alkannins, shikonins and related naphthazarin natural products</article-title><source>Angew Chem Int Ed</source><year>1999</year><volume>38</volume><issue>32</issue><fpage>270</fpage><lpage>300</lpage><pub-id pub-id-type="doi">10.1002/(SICI)1521-3773(19990201)38:3&#x0003c;270::AID-ANIE270&#x0003e;3.0.CO;2-0</pub-id></element-citation></ref><ref id="CR10"><label>10.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Papageorgiou</surname><given-names>VP</given-names></name><name><surname>Assimopoulou</surname><given-names>AN</given-names></name><name><surname>Ballis</surname><given-names>AC</given-names></name></person-group><article-title>Alkannins and shikonins: a new class of wound healing agents</article-title><source>Curr Med Chem</source><year>2008</year><volume>15</volume><issue>30</issue><fpage>3248</fpage><lpage>67</lpage><pub-id pub-id-type="doi">10.2174/092986708786848532</pub-id><pub-id pub-id-type="pmid">19075667</pub-id></element-citation></ref><ref id="CR11"><label>11.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kourounakisa</surname><given-names>AP</given-names></name><name><surname>Assimopoulou</surname><given-names>AN</given-names></name><name><surname>Papageorgiou</surname><given-names>VP</given-names></name><name><surname>Gavalas</surname><given-names>A</given-names></name><name><surname>Kourounakis</surname><given-names>PN</given-names></name></person-group><article-title>Alkannin and shikonin: effect on free radical processes and on inflammation a preliminary pharmacochemical investigation</article-title><source>Arch Pharm (Weinheim)</source><year>2002</year><volume>335</volume><issue>6</issue><fpage>262</fpage><lpage>6</lpage><pub-id pub-id-type="doi">10.1002/1521-4184(200208)335:6&#x0003c;262::AID-ARDP262&#x0003e;3.0.CO;2-Y</pub-id><pub-id pub-id-type="pmid">12210768</pub-id></element-citation></ref><ref id="CR12"><label>12.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Papageorgiou</surname><given-names>VP</given-names></name></person-group><article-title>Wound healing properties of naphthaquinone pigments from <italic>Alkannatinctoria</italic></article-title><source>Experientia</source><year>1978</year><volume>34</volume><issue>11</issue><fpage>1499</fpage><lpage>501</lpage><pub-id pub-id-type="doi">10.1007/BF01932375</pub-id><pub-id pub-id-type="pmid">720485</pub-id></element-citation></ref><ref id="CR13"><label>13.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Basketter</surname><given-names>DA</given-names></name><name><surname>Reynolds</surname><given-names>FS</given-names></name><name><surname>York</surname><given-names>M</given-names></name></person-group><article-title>Irritant dermatitis</article-title><source>Clin Dermatol</source><year>1997</year><volume>15</volume><issue>4</issue><fpage>637</fpage><lpage>44</lpage><pub-id pub-id-type="doi">10.1016/S0738-081X(97)00065-5</pub-id><pub-id pub-id-type="pmid">9255475</pub-id></element-citation></ref><ref id="CR14"><label>14.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tardiff</surname><given-names>RG</given-names></name><name><surname>Hubner</surname><given-names>RP</given-names></name><name><surname>Graves</surname><given-names>CG</given-names></name></person-group><article-title>Harmonization of thresholds for primary skin irritation from results of human repeated insult patch tests and laboratory animal skin irritation tests</article-title><source>J Appl Toxicol</source><year>2003</year><pub-id pub-id-type="pmid">12884413</pub-id></element-citation></ref><ref id="CR15"><label>15.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wiechula</surname><given-names>R</given-names></name></person-group><article-title>The use of moist wound-healing in the management of split-thickness skin graft donor sites: a systematic review</article-title><source>Int J Nurs Pract</source><year>2003</year><volume>9</volume><issue>Suppl 2</issue><fpage>9</fpage><lpage>17</lpage><pub-id pub-id-type="doi">10.1046/j.1322-7114.2003.00417.x</pub-id></element-citation></ref><ref id="CR16"><label>16.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Karlsson</surname><given-names>M</given-names></name><name><surname>Lindgren</surname><given-names>M</given-names></name><name><surname>Jarnhed-Andersson</surname><given-names>I</given-names></name><name><surname>Tarpila</surname><given-names>E</given-names></name></person-group><article-title>Dressing the split-thickness skin graft donor site: a randomized clinical trial</article-title><source>Adv Skin Wound Care</source><year>2014</year><volume>27</volume><issue>1</issue><fpage>20</fpage><lpage>5</lpage><pub-id pub-id-type="doi">10.1097/01.ASW.0000437786.92529.22</pub-id><pub-id pub-id-type="pmid">24343389</pub-id></element-citation></ref><ref id="CR17"><label>17.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Demirtas</surname><given-names>Y</given-names></name><name><surname>Yagmur</surname><given-names>C</given-names></name><name><surname>Soylemez</surname><given-names>F</given-names></name><name><surname>Ozturk</surname><given-names>N</given-names></name><name><surname>Demir</surname><given-names>A</given-names></name></person-group><article-title>Management of split-thickness skin graft donor site: a prospective clinical trial for comparison of five different dressing materials</article-title><source>Burns</source><year>2010</year><volume>36</volume><fpage>999</fpage><lpage>1005</lpage><pub-id pub-id-type="doi">10.1016/j.burns.2009.05.017</pub-id><pub-id pub-id-type="pmid">20381967</pub-id></element-citation></ref><ref id="CR18"><label>18.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Br&#x000f6;lmann</surname><given-names>FE</given-names></name><name><surname>Eskes</surname><given-names>AM</given-names></name><name><surname>Goslings</surname><given-names>JC</given-names></name><name><surname>Niessen</surname><given-names>FB</given-names></name><name><surname>de Bree</surname><given-names>R</given-names></name><name><surname>Vahl</surname><given-names>AC</given-names></name><etal/></person-group><article-title>Randomized clinical trial of donor-site wound dressings after split-skin grafting</article-title><source>Br J Surg</source><year>2013</year><volume>100</volume><issue>5</issue><fpage>619</fpage><lpage>27</lpage><pub-id pub-id-type="doi">10.1002/bjs.9045</pub-id><pub-id pub-id-type="pmid">23460253</pub-id></element-citation></ref><ref id="CR19"><label>19.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>J</given-names></name><name><surname>Chen</surname><given-names>J</given-names></name><name><surname>Kirsner</surname><given-names>R</given-names></name></person-group><article-title>Pathophysiology of acute wound healing</article-title><source>Clin Dermatol</source><year>2007</year><volume>25</volume><issue>1</issue><fpage>9</fpage><lpage>18</lpage><pub-id pub-id-type="doi">10.1016/j.clindermatol.2006.09.007</pub-id><pub-id pub-id-type="pmid">17276196</pub-id></element-citation></ref><ref id="CR20"><label>20.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Greaves</surname><given-names>NS</given-names></name><name><surname>Ashcroft</surname><given-names>KJ</given-names></name><name><surname>Baguneid</surname><given-names>M</given-names></name><name><surname>Bayat</surname><given-names>A</given-names></name></person-group><article-title>Current understanding of molecular and cellular mechanisms in fibroplasia and angiogenesis during acute wound healing</article-title><source>J Dermatol Sci</source><year>2013</year><volume>72</volume><issue>3</issue><fpage>206</fpage><lpage>217</lpage><pub-id pub-id-type="doi">10.1016/j.jdermsci.2013.07.008</pub-id><pub-id pub-id-type="pmid">23958517</pub-id></element-citation></ref><ref id="CR21"><label>21.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rennekampff</surname><given-names>HO</given-names></name><name><surname>Hansbrough</surname><given-names>JF</given-names></name><name><surname>Kiessig</surname><given-names>V</given-names></name><name><surname>Dore</surname><given-names>C</given-names></name><name><surname>Sticherling</surname><given-names>M</given-names></name><name><surname>Schr&#x000f6;der</surname><given-names>JM</given-names></name></person-group><article-title>Bioactive interleukin-8 is expressed in wounds and enhances wound healing</article-title><source>J Surg Res</source><year>2000</year><volume>93</volume><issue>1</issue><fpage>41</fpage><lpage>54</lpage><pub-id pub-id-type="doi">10.1006/jsre.2000.5892</pub-id><pub-id pub-id-type="pmid">10945942</pub-id></element-citation></ref><ref id="CR22"><label>22.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Assimopoulou</surname><given-names>AN</given-names></name><name><surname>Papageorgiou</surname><given-names>VP</given-names></name></person-group><article-title>Radical scavenging activity of <italic>Alkanna tinctoria</italic> root extracts and their main constituents, hydroxyl naphthoquinones</article-title><source>Phytother Res</source><year>2005</year><volume>19</volume><issue>2</issue><fpage>141</fpage><lpage>7</lpage><pub-id pub-id-type="doi">10.1002/ptr.1645</pub-id><pub-id pub-id-type="pmid">15852495</pub-id></element-citation></ref><ref id="CR23"><label>23.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ogurtan</surname><given-names>Z</given-names></name><name><surname>Hatipoglu</surname><given-names>F</given-names></name><name><surname>Ceylan</surname><given-names>C</given-names></name></person-group><article-title>The effect of <italic>Alkanna tinctoria</italic> Tausch on burn wound healing in rabbits</article-title><source>Dtsch Tierarztl Wochenschr</source><year>2002</year><volume>109</volume><issue>11</issue><fpage>481</fpage><lpage>5</lpage><pub-id pub-id-type="pmid">12494554</pub-id></element-citation></ref><ref id="CR24"><label>24.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Karayannopoulou</surname><given-names>M</given-names></name><name><surname>Tsioli</surname><given-names>V</given-names></name><name><surname>Loukopoulos</surname><given-names>P</given-names></name><name><surname>Anagnostou</surname><given-names>TL</given-names></name><name><surname>Giannakas</surname><given-names>N</given-names></name><name><surname>Savvas</surname><given-names>I</given-names></name><name><surname>Papazoglou</surname><given-names>LG</given-names></name><name><surname>Kaldrymidou</surname><given-names>E</given-names></name></person-group><article-title>Evaluation of the effectiveness of an ointment based on Alkannins/Shikonins on second intention wound healing in the dog</article-title><source>Can J Vet Res</source><year>2011</year><volume>75</volume><issue>1</issue><fpage>42</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">21461194</pub-id></element-citation></ref><ref id="CR25"><label>25.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Khorasani</surname><given-names>G</given-names></name><name><surname>Ahmadi</surname><given-names>A</given-names></name><name><surname>Jalal Hosseinimeh</surname><given-names>S</given-names></name><name><surname>Ahmadi</surname><given-names>A</given-names></name><name><surname>Taheri</surname><given-names>A</given-names></name><name><surname>Fathi</surname><given-names>H</given-names></name></person-group><article-title>The Effects of Aloe Vera Cream on Split thickness Skin Graft Donor Site Management: A randomized, blinded, placebo-controlled study</article-title><source>Wounds</source><year>2011</year><volume>23</volume><issue>2</issue><fpage>44</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">25881055</pub-id></element-citation></ref></ref-list></back></article>